Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC GSK3368715 | 1629013-22-4 | 99.4% | 10 MG
SDP

Catalog No. 5000341069
Encompass_Preferred

GSK3368715 is an orally active, reversible type I protein arginine methyltransferases (PRMTs) inhibitor. It induces a shift in arginine methylation states, modifies exon usage, and exhibits strong anti-cancer activity, making it suitable for oncology research.

  • Orally active and reversible inhibitor
  • Inhibits type I protein arginine methyltransferases (PRMTs)
  • Induces shifts in arginine methylation states
  • Modifies exon usage
  • Demonstrates strong anti-cancer activity
  • Effective against a broad range of cancer cell lines
  • Target: Histone Methyltransferase
  • Pathway: Epigenetics

Catalog No. 50-003-41069 Supplier Medchemexpress LLC Supplier No. HY12871710MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

GSK3368715 is an orally active, reversible type I protein arginine methyltransferases (PRMTs) inhibitor. It induces a shift in arginine methylation states, modifies exon usage, and exhibits strong anti-cancer activity, making it suitable for oncology research.

  • Orally active and reversible inhibitor
  • Inhibits type I protein arginine methyltransferases (PRMTs)
  • Induces shifts in arginine methylation states
  • Modifies exon usage
  • Demonstrates strong anti-cancer activity
  • Effective against a broad range of cancer cell lines
  • Target: Histone Methyltransferase
  • Pathway: Epigenetics

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.